Cytori Therapeutics (CYTX) Income Statement

Click line-items for a historical chart and %

Related party
Third party
Total product revenues	1.47M
Cost of product revenues	945K
Gross profit	521K
Development, related party
Research grant and other
Total Development Revenues
Research and development	2.86M
Sales and marketing	869K
General and administrative	1.94M
Change in fair value of warrant liability
Change in fair value of option liability
Total operating expenses	5.67M
Operating loss	-3.59M
Interest income	11K
Interest expense	-645K
Other income (expense), net	-696K
Equity loss from investment in joint venture
Total other income (expense)	-1.33M
Net loss	-4.92M
Basic and diluted net loss per common share
Basic and diluted weighted average common shares

Entities mentioned with CYTX

View All Entities